Thermo Fisher Scientific (TMO) DIvidends Date & History

Key Takeaways

• Thermo Fisher Scientific pays a quarterly dividend currently at $0.47 per share, resulting in an annual total of $1.88.
• The dividend yield stands at approximately 0.35%, reflecting a modest payout relative to the stock price.
• The company has raised its dividend for nine consecutive years with average annual growth around 10-13%.
• Payout ratio remains low at about 9-10%, indicating strong earnings coverage and sustainability.
• Free cash flow comfortably supports the dividend, supporting long-term reliability for income-focused investors.
• The profile suits dividend growth investors seeking consistency over high current income.

Dividend Overview

Thermo Fisher Scientific maintains a quarterly dividend policy with payments typically issued in January, April, July, and October. The most recent quarterly dividend is $0.47 per share, following a 10% increase announced earlier in 2026. This results in an annualized dividend of $1.88 and a current yield near 0.35%. The company operates as a dividend growth stock rather than a high-yield name, prioritizing consistent increases alongside robust business expansion in life sciences and analytical instruments. Its modest yield aligns with a strategy focused on reinvestment and shareholder returns through measured payouts.

Dividend History and Growth

Thermo Fisher Scientific initiated regular dividends in the early 2010s and has delivered consistent annual increases since then. The dividend has grown at an average rate of 10% over the past year, 12% over three years, and higher rates over longer periods. Recent quarterly amounts progressed from $0.35 in 2023 to $0.39 in 2024 and $0.43 in 2025 before reaching $0.47 in 2026. This pattern demonstrates a commitment to dividend growth without interruption, establishing a nine-year streak of annual raises. The approach reflects a long-term strategy of sharing profits with shareholders while maintaining flexibility for acquisitions and research investments.

Dividend Sustainability and Payout Ratio

The dividend appears highly sustainable given the low payout ratio of approximately 9-10% of earnings. This leaves substantial room for future increases and buffers against earnings fluctuations. Earnings and free cash flow provide ample coverage, with the dividend representing only a small fraction of available cash generation. Debt levels remain manageable within the company's strong balance sheet, supporting ongoing dividend payments. Overall financial stability in the life sciences sector further reinforces the outlook for continued reliability, as Thermo Fisher Scientific generates consistent operating cash flows from its diversified product portfolio.

Dividend Compared to Industry Peers

Within the life sciences and healthcare equipment sector, Thermo Fisher Scientific's dividend yield of around 0.35% falls below many peers such as Danaher and Agilent Technologies, which typically offer yields in the 0.4-0.6% range alongside similar growth profiles. The company's low payout ratio and dividend growth streak compare favorably to industry averages, where many competitors maintain modest yields to fund innovation. This positions TMO as a conservative income option relative to higher-yielding healthcare names but competitive on growth metrics.

AI Screener

AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify dividend stocks, income-focused investments, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Investors seeking dividend opportunities can explore the platform for tailored results.

Is This Stock Attractive for Dividend Investors?

Thermo Fisher Scientific appeals primarily to dividend growth investors and long-term holders who value consistent annual increases and low payout ratios over high current yields. Its modest dividend suits portfolios emphasizing capital appreciation alongside gradual income growth, particularly within the healthcare and life sciences sector. Conservative income investors may find the yield less compelling compared to higher-yielding alternatives, while those focused on sustainability and reinvestment potential could view the low payout favorably. The company's strong fundamentals support dividend reliability, making it suitable for balanced strategies that combine growth and modest income generation without excessive risk to principal.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations